Black Rose Industries Q4 FY25 earnings call: Revenue & Margins
Q4 FY25 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹83Cr
- −28.1% YoY
- −5.5% QoQ
- Net profit
- ₹6Cr
- +1.9% YoY
- +1.9% QoQ
- Margin
- 10.29%
- +4.1 pp YoY
- +1.1 pp QoQ
Guidance rank: #65 of 70 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
The short version
Standalone sales for FY24-25 have already exceeded FY22 figures in terms of volume. The company has exceeded standalone figures of FY22 in FY24-25, indicating positive volume growth.
From Black Rose Industries Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Standalone sales for FY24-25 have already exceeded FY22 figures in terms of volume.
- Raw material prices have stabilized, aiding better price realization.
- New products like acrylamide solid and N-methylol acrylamide (NMA) are steadily gaining market acceptance.
- Capacity utilization for key products is improving, contributing to better margins and volume growth.
- Export markets, especially in the U.S., may improve once tariff uncertainties clear.
- Company is optimistic about enhancing market share and profitability through new product launches and expanded distribution.
- Ongoing R&D and manufacturing initiatives (e.g., polyacrylamide solid) expected to positively impact growth.
2 more points from Black Rose Industries Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Black Rose Industries Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Polyacrylamide (PAM) solid project is progressing on schedule; commercial production expected by end of the current fiscal or start of next.
- CAPEX for PAM solid estimated between ₹60 to ₹100 crores.
- Additional upcoming projects include an amine manufacturing facility, with a feasibility study underway in collaboration with Koei Chemicals (Japan).
- Total CAPEX for amine and other projects estimated around ₹50 crores.
- Land registration for new parcels is near completion to create a land bank for future projects.
- EC approval for the mines project at Jhagadia site is expected soon.
2 more points from Black Rose Industries Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Black Rose Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Black Rose Industries Ltd's call on order book
Create a free account to keep reading this call
Black Rose Industries Ltd — Quarterly revenue & net profit
Black Rose Industries Ltd Q4 FY25 results — key figures
| ₹ Cr | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue | 83 | 115 | -28.1% | 88 | -5.5% |
| Operating profit (EBITDA) | 9 | 7 | +19.1% | 8 | +5.6% |
| Operating margin | 10.29% | 6.21% | +4.1 pp | 9.21% | +1.1 pp |
| Profit before tax | 8 | 8 | +2% | 8 | +0.8% |
| Net profit (PAT) | 6 | 6 | +1.9% | 6 | +1.9% |
| EPS (₹) | 1.14 | 1.12 | +1.8% | 1.12 | +1.8% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹104 Cr, net profit ₹9 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Black Rose Indus's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Atul (Q4 FY25)
Consolidated revenue from operations for 2024-25: ₹5,583 cr, 18% increase YoY from ₹4,726 cr in 2023-24 (Page 36). Key concall takeaways from Atul Ltd's Q4…
- Vidhi Specialty (Q4 FY25)
109.5 Crs, up 40.2% YoY (from Rs. Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q4 FY25 earnings call — and how it ranks against sector…
- Chemcon Speciality Chemicals (Q4 FY25)
54.9 Crs, down 8% YoY from Rs. Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.
- Valiant Organics (Q4 FY25)
Q4-FY25 revenue from operations (consolidated) was INR 2,038 million, a 15.3% year-on-year (YoY) increase from INR 1,768 million in Q4-FY24 (Page 12 and 10)…
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Black Rose Industries Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Black Rose Industries Ltd Q4 FY25 results?
Standalone sales for FY24-25 have already exceeded FY22 figures in terms of volume. The company has exceeded standalone figures of FY22 in FY24-25, indicating positive volume growth.
What is Black Rose Industries Ltd share price analysis?
Black Rose Industries Ltd currently shows a neutral. The stock trades at a P/E of 20.5 with a market cap of ₹588 Cr. Investors should review the full earnings analysis for detailed insights.
Is Black Rose Industries Ltd planning capital expenditure?
Polyacrylamide (PAM) solid project is progressing on schedule; commercial production expected by end of the current fiscal or start of next.
Keep Black Rose Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
